QSAR studies for the inhibition of the transmembrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 24, Issue 2, 2009, Pages 337-349

  Singh, Shalini ^a   Khadikar, Padmakar V ^b   Scozzafava, Andrea ^c   Supuran, Claudiu T ^c  

^a BAREILLY COLLEGE   (India)

^b Research Division   (India)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Carbonic anhydrase XIV; HyperChem; Inhibition; NCSS; PRECLAV; QSAR; Sulfonamides

Indexed keywords

ACETAZOLAMIDE; ALKYL GROUP; AROMATIC COMPOUND; BENZOLAMIDE; BRINZOLAMIDE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE XIV; DICLOFENAMIDE; DORZOLAMIDE; ETHOXZOLAMIDE; HETEROCYCLIC COMPOUND; MEMBRANE ENZYME; METHAZOLAMIDE; SULFONAMIDE; UNCLASSIFIED DRUG; ZONISAMIDE; CARBONATE DEHYDRATASE INHIBITOR; CARBONIC ANHYDRASE XIV;

ARTICLE; CALCULATION; COMPUTER PROGRAM; CORRELATION ANALYSIS; DRUG STRUCTURE; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; MATHEMATICAL MODEL; PARAMETER; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; CHEMISTRY; METABOLISM;

CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; HUMANS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOFTWARE; SULFONAMIDES;

EID: 68049107306     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360802187489     Document Type: Article

References (35)

1. Supuran CT. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nature Rev Drug Disc 2008;7:168-181.
2. Mincione F, Menabuoni L, Supuran CT. Clinical applications of the Carbonic anhydrase inhibitors in ophthalmology. In: Supuran C, Scozzafava A, Conway J, editors. Carbonic anhydrase, its inhibitors and activators. Boca Raton (FL): CRC Press; 2004. p 243-254.
3. Supuran CT, Scozzafava A, Conway J, editors. Carbonic anhydrase-its inhibitors and activators. Boca Raton (USA): CRC Press; 2004. p 1-363.
4. Clare BW, Supuran CT. QSAR studies of sulfonamide carbonic anhydrase inhibitors. In: Supuran CT, Scozzatava A, Conway J, editors. Carbonic andydrase, its inhibitors and activators. Boca Raton, FI, USA: CRC Press; 2004.
5. Supuran CT. Carbonic anhydrases: Catalytic and inhibition mechanisms, distribution and physiological roles. In: Pacscas I, editor. Carbonic anhydrase and modulation of physiologic and pathologic process in the organism. Timisoara (Romania): Helicon; 1994. p 29-111.
6. Supuran CT, Scozzafava A, Casini A. Development of sulfonamide carbonic anhydrase inhibitors (CAIs). In: Supuran CT, Scozzafava A, Conway J, editors. Carbonic anhydrase, its inhibitors and activators. Boca Raton (FL): CRC Press; 2004. p 67-148.
7. Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146-189.
8. Fujikawa-adachi K, Nishimori I, Taguchi T, Onishi S. J Biol Chem 1999;274:21228.
9. Asida S, Nishimori I, Tanimura M, Onishi S, Shuri T. J Cancer Res Clin Oncol 2002;128:561.
10. Clare BW, Supuran CT. A perspective on quantitative structure-activity relationships and carbonic anhydrase inhibitors. Expert Opin Drug Metab Toxicol 2006;2:113.
11. Singh J, Singh S, Khadikar PV, Supuran CT, Clare BW, Lakhwani M. Estimation of human carbonic anhydrase II inhibition using topological indices and their combination with quantum- theoretical descriptors. Med Chem 2008;4:30-66.
12. Supuran CT, Scozzafava A, Conway J, editors. Carbonic anhydrase-its inhibitors and activators. Boca Raton (USA): CRC Press; 2004. p 1-363.
13. Agrawal VK, Singh J, Pandey A, Khadikar PV. Modeling of inhibitory activities of sulfonamide schiff bases using physicochemical parameters. Oxid Commun 2006;29: 803-816.
14. Tarko L. QSAR studies regarding the inihibition of the carbonic anhydrase by the sulfonamides containing a picolinyl group. Rev Chim (Bucuresti) 2007;58:191-194.
15. Khadikar PV, Clare BW, Balaban AT, Supuran CT, Agrawal VK, Singh J, Joshi AK, Lakhwani M. QSAR predection of CAI, CAII, CAIV inhibitory activities: Relative potential of balaban and balaban type indices. Rev Roum Chem 2006;51: 703-717.
16. Jaiswal M, Khadikar PV, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: The first QSAR study on inhibition of tumour associated isoenzyme IX with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett 2004;14: 3283-3290. (Pubitemid 38624608)
17. Khadikar PV, Diudea MV, Singh J, Shrivastva A, Singh S, Karmarkar S, Lakhwani M, Thakur P. Use of PI index in computer-aided designing of bioactive compounds. Curr Bioact Comp 2006;2:19-56.
18. Agrawal VK, Bano S, Supuran CT, Khadikar PV. QSAR study on carbonic anhydrase inhibitors: Aromatic/heterocyclic sulfonamides containing 8-quinoline moieties with topical activity as anti-glauoma agents. Eur JMed Chem 2004;39:593-600.
19. Khadikar PV, Sharma V, Karmarkar S, Supuran CT. QSAR studies on benzene sulfonamide carbonic anhydrase inhibitors: Need of hydrophobic parameter for topological modeling of binding constants of sulfonamides to human CA-II. Bioorg Med Chem Lett 2005;15:923-930.
20. Khadikar PV, Clare BW, Balaban AT, Supuran CT, Agrawal VK, Singh J, Joshi AK, Lakhwani M. QSAR predection of CAI,CAII, CAIV inhibitory activities: Relative potential of balaban and balaban type indices. Rev Roum Chem 2006;51: 703-717.
21. Khadikar PV, Jaliwala YA, Lakhwani M, Thakur P, Joshi S, Joshi AK. QSAR studies on inhibitoty properties of benzinesulphonamides towards CA-I: Domaminating role of van derWaals repulsion energy. Bioinformatics Trends 2006;1: 125-136.
22. Khadikar PV, Clare BW, Balaban AT, Supuran CT, Agrawal VK, Singh J, Joshi AK, Lakhwani M. Estimation of human carbonic anhydrase II inhibition using topological indices and their combination with quantum- theoretical descriptors. J Med Chem Res 2006;15:156-160.
23. Agrawal VK, Singh J, Pandey A, Khadikar PV. Modeling of inhibitory activities of sulfonamide schiff bases using physicochemical parameters. Oxid Commun 2006;29:803-816.
24. Khadikar PV, Deeb O, Jaber A, Singh J, Lakhwani M. Development of quantitative structure- activity relationship for a set of carbonic anhydrase inihibitors: Use of quantum and chemical descriptors. Lett Drug Design Discov 2006;3: 622-635.
25. Balaban AT, Khadikar PV, Supuran CT, Thakur A, Thakur M. Study on supramolecular complexing ability vis-à-vis estimation of pKa of substituted sulfonamides: Dominating role of balaban index (J). Bioorg Med Chem Lett 2005;15: 3966-3973.
26. Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inihibitors: Inihibition of the transmembrane isozyme XIV with sulfomamides. Bioorg Med Chem Lett 2005;15:3828-3833.
27. Tarko L, Lupescu I, Groposila-Constantinescu D. Sweetness power QSARs by PRECLAV software. Arkivoc 2005;10: 254-271.
28. PRECLAV v.0601 program is available from Center of Organic Chemistry (CCO) Bucharest, Romanian Academy; Director CCO E-mail address: Pfilip@cco.ro
29. HyperChem7.52 Software, Hypercube Inc. Florida Science and Technology Park,1115 N.W. 4th street Gainesvilla Florida, 326001, USA; 2006. http://www.hyper.com/
30. ADDREIT T., STANCU S., Statistica, Ed. ALL, Bucuresti, 1995, p 341.
31. Sybyl 7.2 Tripos Inc., 1699 Hanley Road, St.Louis MO 63144see www.tripos.com
32. Vinter JG, Davis A, Saunders MR. J Comp-Aided Design Mol 1987;1:31.
33. Stewart JJP. Mopac93, Fujitsu Ltd., Tokyo, Japa.
34. Charterjee S, Hadi AS, Price B. Regression analysis by examples. 3rd ed. New York: Wiley; 2000.
35. NCSS(statistical Software Delux package), 329 North 1000 East; Kaysville, UT, USA, 2004.